Global Diagnostic Testing of STDs Market Is Expected to Reach an Estimated Value of US $108.5 Billion by the End of 2019

Albany, NY -- (SBWIRE) -- 08/28/2015 -- Sexually Transmitted Diseases (STDs), also known as sexually transmitted infections (STIs), or venereal diseases (VDs) are diseases that spread majorly through person-to-person sexual contact. Indicative testing of STDs refers to testing technologies that are used for examining and identifying the type of STD. Diagnostic testing of STDs is typically done in the laboratories or at the point-of-care (POC). Sexually transmitted diseases (STDs) could be caused by more than 30 distinctive viruses, parasites, and bacteria and are essentially spread by sexual contact and at times by non-sexual means. Diagnostic testing for STDs is regarded as being particularly crucial since these can have serious effects on sexual and reproductive wellbeing - extending from infertility and pelvic inflammatory diseases to AIDS and cervical cancer.